Waters xevo G2-XS qtof with acquity H-class plus BIO system and accessories, installation, training, and optional service agreements.

Ended Purchase Order Awarded

Contract number
75N95020P00760
Awardee
Awarding agency
Obligated
$335,025

Award facts

Opportunity
Contract value 67% obligated
  • $335,024.63 Current, with exercised options
  • $499,577.18 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
Total Small Business
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
New Brunswick, NJ 08901, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $499,577 fixed-price purchase order to Cenmed Enterprises Inc., doing business as Cenmed, located in New Brunswick, New Jersey. The order is for a Waters Xevo G2-XS QTOF mass spectrometry system with an ACQUITY H-Class Plus Bio System and associated accessories, installation, training, and service agreements. The solicitation specifically requested quotations from small businesses for this brand name or equal equipment to replace an existing Agilent 6210 time of flight mass spectrometer. With a period of performance from September 2020 to September 2025, this total small business set-aside award will provide the National Institutes of Health campus in Rockville, Maryland with the requested mass spectrometry technologies and services to support the agency's biomedical research efforts.

Quick answers

Who was awarded contract 75N95020P00760?

75N95020P00760 was awarded to Cenmed Enterprises Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 29, 2020.

How much is contract 75N95020P00760 worth?

The government has obligated $335,025 on 75N95020P00760. Its potential value, with all options, is $499,577.

Which agency awarded contract 75N95020P00760?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020P00760, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Was contract 75N95020P00760 competed?

The extent of competition for 75N95020P00760 was competed under sap. The government received 2 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award